A dozen pharmaceutical companies have paid doctors in the US nearly $150m so far this year, according to industry data that suggests an increase in these controversial marketing and support practices.
The figures highlight the extent of entertainment, travel, consulting, education and research support to doctors – payments that the industry says are ethical and enhance health outcomes, but which critics believe can influence prescribing practices.
Ver
Paga:
Novartis
Glaxo
Lilly
AstraZeneca
y también
Pfizer
Medtronic
Janssen
...
Ver anterior
Entradas
No hay comentarios:
Publicar un comentario